Development of Asialoglycoprotein Receptor-Targeted Nanoparticles for Selective Delivery of Gemcitabine to Hepatocellular Carcinoma
Molecules - Switzerland
doi 10.3390/molecules24244566
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 13, 2019
Authors
Publisher
MDPI AG